John F. Crowley - 15 Jun 2022 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role
Chairman & CEO, Director
Signature
/s/ Christian Formica, Attorney-in-Fact
Issuer symbol
FOLD
Transactions as of
15 Jun 2022
Net transactions value
-$83,839
Form type
4
Filing time
17 Jun 2022, 17:46:30 UTC
Previous filing
16 Jun 2022
Next filing
06 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Sale $83,839 -10,468 -1.1% $8.01 922,339 15 Jun 2022 Direct F1, F2
holding FOLD Common Stock 64,895 15 Jun 2022 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $8.00 to $8.05 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

In addition to the reported transactions, Mr. Crowley also has approximately 502,000 options outstanding and exercisable at various strike prices.